Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UBX
3076
DELISTED
Unity Biotechnology
UBX
| $667K | ﹤0.01% |
14,358
-8,282
| -37% | -$399K |
|
3077
Pure Cycle
PCYO
$258M
| $663K | ﹤0.01% |
47,923
-2,299
| -5% | -$32.9K |
|
3078
Northrim BanCorp
NRIM
$586M
| $661K | ﹤0.01% |
61,808
-768
| -1% | -$8.35K |
|
3079
Aemetis
AMTX
$110M
| $659K | ﹤0.01% |
+58,974
| New | +$930K |
|
|
ESTE
3080
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $657K | ﹤0.01% |
59,341
-4,729
| -7% | -$42.9K |
|
3081
Alta Equipment Group
ALTG
$197M
| $651K | ﹤0.01% |
48,976
+4,439
| +10% | +$60.6K |
|
3082
CorMedix
CRMD
$588M
| $647K | ﹤0.01% |
94,289
+11,711
| +14% | +$93.2K |
|
3083
Orrstown Financial Services
ORRF
$841M
| $647K | ﹤0.01% |
28,033
| – | – |
|
|
INFI
3084
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $645K | ﹤0.01% |
215,572
+185,624
| +620% | +$587K |
|
|
PVBC
3085
DELISTED
Provident Bancorp
PVBC
| $644K | ﹤0.01% |
39,430
-1,713
| -4% | -$27.6K |
|
|
PCSB
3086
DELISTED
PCSB Financial Corporation
PCSB
| $641K | ﹤0.01% |
35,225
-738
| -2% | -$13.2K |
|
3087
Covenant Logistics
CVLG
$928M
| $640K | ﹤0.01% |
61,860
| – | – |
|
3088
Target Hospitality
TH
$1.44B
| $639K | ﹤0.01% |
172,215
+801
| +0.5% | +$2.65K |
|
3089
Fortress Biotech
FBIO
$109M
| $635K | ﹤0.01% |
11,848
+474
| +4% | +$28.6K |
|
3090
KALA BIO
KALA
$13.6M
| $631K | ﹤0.01% |
48
+7
| +17% | +$110K |
|
|
CASI
3091
DELISTED
CASI Pharmaceuticals
CASI
| $629K | ﹤0.01% |
40,529
-10,144
| -20% | -$171K |
|
3092
LiveOne
LVO
$61.6M
| $629K | ﹤0.01% |
13,322
| – | – |
|
|
RYZ
3093
Ryerson Holding Corp
RYZ
$1.39B
| $627K | ﹤0.01% |
42,941
+1,805
| +4% | +$28.5K |
|
3094
South Plains Financial
SPFI
$842M
| $625K | ﹤0.01% |
26,987
| – | – |
|
3095
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $623K | ﹤0.01% |
7,079
-336
| -5% | -$29.3K |
|
3096
nCino
NCNO
$2.01B
| $623K | ﹤0.01% |
10,397
+508
| +5% | +$32K |
|
|
SMMF
3097
DELISTED
Summit Financial Group, Inc.
SMMF
| $622K | ﹤0.01% |
28,242
| – | – |
|
|
FTSI
3098
DELISTED
FTS International, Inc. Common Stock
FTSI
| $621K | ﹤0.01% |
+21,944
| New | +$569K |
|
3099
Consolidated Water Co
CWCO
$474M
| $620K | ﹤0.01% |
52,800
-29,993
| -36% | -$371K |
|
3100
UroGen Pharma
URGN
$2B
| $619K | ﹤0.01% |
40,515
-338
| -0.8% | -$6.11K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.